5-Bromo-2-(1H-pyrazol-3-yl)pyridine

Catalog No.: 
ACIMBZ296
CAS No.: 
811464-25-2
Molecular Formula: 
C8H6BrN3
Molecular Weight: 
224.06
5-Bromo-2-(1H-pyrazol-3-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$104.00InquiryInquiry
100mg95%$148.00InquiryInquiry
250mg95%$203.00InquiryInquiry
1g95%$496.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-(1H-pyrazol-3-yl)pyridine
IUPAC Name5-Bromo-2-(1H-pyrazol-3-yl)pyridine
MDL No.MFCD13193159
Molecular FormulaC8H6BrN3
Molecular Weight224.06
SMILESBrC1=CN=C(C2=NNC=C2)C=C1
InChI KeyHTQYPOCKOBSRSX-UHFFFAOYSA-N
Synonym5-BroMo-2-(1H-pyrazol-3-yl)pyridine;5-bromo-2-(1H-pyrazol-5-yl)pyridine;Pyridine, 5-bromo-2-(1H-pyrazol-3-yl)-
CAS No.811464-25-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIMBZ296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYIHU365 route compound structure diagram
    ACYIHU36553939-30-3In Stock
  4. Then
  5. ACIMBZ296 route product structure diagram
    ACIMBZ296811464-25-2
Inquiry

2. ACIMBZ296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIMBZ296 route product structure diagram
    ACIMBZ296811464-25-2
Inquiry

3. ACIMBZ296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIMBZ296 route product structure diagram
    ACIMBZ296811464-25-2
Inquiry

Comments (0)